Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma

R Eguchi1, T Nakano2, I Wakabayashi1

  • 1Department of Environmental and Preventive Medicine, Hyogo College of Medicine, Hyogo, Japan.

Oncogene
|June 28, 2016
PubMed

Insights

Malignant mesothelioma cells release granulin (GRN) proteins that promote blood vessel growth independently of VEGF. This finding offers new targets for mesothelioma treatment by revealing a VEGF-independent angiogenesis pathway.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Malignant mesothelioma is an aggressive cancer linked to tumor angiogenesis.
  • Vascular endothelial growth factors (VEGFs) are key in angiogenesis, but anti-VEGF therapies like bevacizumab show limited efficacy in mesothelioma.
  • Serum in cell cultures can obscure the detection of novel angiogenic factors.

Purpose of the Study:

  • To identify novel mesothelioma-derived factors that promote angiogenesis independently of VEGF.
  • To investigate the role of these factors in mesothelioma progression.

Main Methods:

  • Serum-free culture of human mesothelioma cell lines (NCI-H2052, NCI-H28, NCI-H2452).
  • Assay of conditioned media for induction of capillary-like tube formation in endothelial cells.
  • Mass spectrometry to identify proteins in the supernatant.
  • Neutralization assays and RNA interference to determine the role of candidate proteins, including granulin (GRN).

Main Results:

  • Serum-free supernatant from NCI-H2052 cells induced tube formation, independent of VEGF-A or VEGF receptor 2 (VEGFR2).
  • Mass spectrometry identified 399 proteins, with granulin (GRN), also known as progranulin (PGRN), identified as a key inducer of angiogenesis.
  • PGRN, and GRN-like proteins, were confirmed to drive tube formation, and were expressed by NCI-H28 and NCI-H2452 cells.

Conclusions:

  • Mesothelioma-derived granulin proteins (GRNs) induce VEGF-independent angiogenesis.
  • GRNs represent a novel therapeutic target for malignant mesothelioma, distinct from VEGF-targeted therapies.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K